

A pioneering geneticist whose research unlocked the molecular causes of severe skin and hair disorders, transforming patient diagnosis.
Irwin McLean, an Irish scientist who spent his career at the University of Dundee, dedicated his work to solving some of the most distressing puzzles in human genetics. His laboratory became a global hub for discovering the faulty genes responsible for a spectrum of debilitating conditions that affect the skin, hair, and nails. McLean and his team made landmark discoveries, pinpointing the genetic mutations that cause diseases like epidermolysis bullosa, a painful condition where the skin blisters from minor trauma, and a major form of alopecia. This wasn't just academic; his work provided concrete answers to families and paved the way for potential future therapies. By mapping these genetic errors, McLean shifted the entire field from descriptive symptomology to precise molecular understanding, offering hope through knowledge.
1946–1964
The largest generation in history at the time. Shaped by postwar prosperity, the Vietnam War, the sexual revolution, and Watergate. They questioned every institution their parents built — then ran them.
Irwin was born in 1963, placing them squarely in the Baby Boomers. The events that shaped this generation — postwar prosperity, civil rights, Vietnam, and the counterculture — shaped the world they entered and the choices available to them.
The biggest hits of 1963
#1 Movie
Cleopatra
Best Picture
Tom Jones
#1 TV Show
Beverly Hillbillies
The world at every milestone
JFK assassinated in Dallas; Martin Luther King's 'I Have a Dream' speech
Martin Luther King Jr. and Robert Kennedy assassinated
Apple Computer founded; US bicentennial
Iran hostage crisis begins; Three Mile Island accident
MTV launches; first Space Shuttle flight; AIDS identified
Apple Macintosh introduced
European Union officially established
US invades Iraq; Human Genome Project completed
Edward Snowden reveals NSA surveillance programs
ChatGPT goes mainstream; Israel-Hamas war begins
He is an elected member of the European Molecular Biology Organization (EMBO).
His research has been cited by other scientists tens of thousands of times.
He has collaborated widely with international patient advocacy groups for rare genetic disorders.
“Every gene we find is a starting point, not an end; it's a clue for a family waiting for answers.”